nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Diet, Lifestyle, and Nonstatin Trials: Review of Time to Benefit
|
Denke, Margo A. |
|
2005 |
96 |
5S |
p. 3-10 8 p. |
artikel |
2 |
Different Time Course for Prevention of Coronary and Stroke Events by Atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid-Lowering Arm (ASCOT-LLA)
|
Sever, Peter S. |
|
2005 |
96 |
5S |
p. 39-44 6 p. |
artikel |
3 |
Early Time to Benefit with Intensive Statin Treatment: Could It Be the Pleiotropic Effects?
|
Ray, Kausik K. |
|
2005 |
96 |
5S |
p. 54-60 7 p. |
artikel |
4 |
Effect of Intensive Lipid Lowering on Progression of Coronary Atherosclerosis: Evidence for an Early Benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Trial
|
Nissen, Steven E. |
|
2005 |
96 |
5S |
p. 61-68 8 p. |
artikel |
5 |
Effects of Statins on 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition Beyond Low-Density Lipoprotein Cholesterol
|
Liao, James K. |
|
2005 |
96 |
5S |
p. 24-33 10 p. |
artikel |
6 |
Intermolecular Differences of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Contribute to Distinct Pharmacologic and Pleiotropic Actions
|
Mason, R. Preston |
|
2005 |
96 |
5S |
p. 11-23 13 p. |
artikel |
7 |
Introduction
|
Braunwald, Eugene |
|
2005 |
96 |
5S |
p. 1-2 2 p. |
artikel |
8 |
Review of Primary and Secondary Prevention Trials with Lovastatin, Pravastatin, and Simvastatin
|
Gotto Jr, Antonio M. |
|
2005 |
96 |
5S |
p. 34-38 5 p. |
artikel |
9 |
Safety of High-Dose Atorvastatin Therapy
|
Waters, David D. |
|
2005 |
96 |
5S |
p. 69-75 7 p. |
artikel |
10 |
The Case for Intensive Statin Therapy After Acute Coronary Syndromes
|
Schwartz, Gregory G. |
|
2005 |
96 |
5S |
p. 45-53 9 p. |
artikel |